Search Results - "Prostate cancer"

Validation and three years of clinical experience in using an artificial intelligence algorithm as a second read system for prostate cancer diagnosis-real-world experience by Juan Carlos Santa-Rosario, Erik A. Gustafson, Dario E. Sanabria Bellassai, Phillip E. Gustafson, Mariano de Socarraz

Connect to this object online.

Scutellaria barbata D.Don (SBD) extracts suppressed tumor growth, metastasis and angiogenesis in Prostate cancer via PI3K/Akt pathway by Dongya Sheng, Bei Zhao, Wenjing Zhu, Tiantian Wang, Yu Peng

Connect to this object online.

Uptake of prostate cancer screening and associated factors among men aged 50 years and above in Lira city, Uganda: a cross-sectional study by Richard Ekwan, Emmanuel Bua, Ritah Nantale, Ronald Opito, Patrick Abingwa, Quraish Sserwanja, Job Kuteesa, David Mukunya

Connect to this object online.

Naringenin modulates the metastasis of human prostate cancer cells by down regulating the matrix metalloproteinases -2/-9 via ROS/ERK1/2 pathways by Er-Jiang Lin, Xian Zhang, Da-Ya Wang, Shi-Zhe Hong, Lei-Yu Li

Connect to this object online.

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel by Jian-Ri Li, Jian-Ri Li, Jian-Ri Li, Kun-Yuan Chiu, Kun-Yuan Chiu, Shian-Shiang Wang, Shian-Shiang Wang, Shian-Shiang Wang, Cheng-Kuang Yang, Chuan-Shu Chen, Hao-Chung Ho, Chi-Feng Hung, Chen-Li Cheng, Chen-Li Cheng, Chi-Rei Yang, Cheng-Che Chen, Shu-Chi Wang, Chia-Yen Lin, Chao-Hsiang Chang, Chiann-Yi Hsu, Yen-Chuan Ou, Yen-Chuan Ou, Yen-Chuan Ou, Yen-Chuan Ou

Connect to this object online.

Serotonin receptor 4 (5-hydroxytryptamine receptor Type 4) regulates expression of estrogen receptor beta and cell migration in hormone-naive prostate cancer by Yasuhiro Nakamura, Kazue Ise, Yuto Yamazaki, Fumiyoshi Fujishima, Keely M McNamara, Hironobu Sasano

Connect to this object online.

miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling by Shuai Huang, Changye Zou, Yubo Tang, Qingde Wa, Xinsheng Peng, Xiao Chen, Chunxiao Yang, Dong Ren, Yan Huang, Zhuangwen Liao, Sheng Huang, Xuenong Zou, Jincheng Pan

Connect to this object online.

Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes by Amin Ullah, Yongxiu Chen, Rajeev K. Singla, Dan Cao, Bairong Shen

Connect to this object online.

Effect of Perceived Self-Vulnerability on Prostate Cancer Screening Uptake and Associated Factors: A Cross-Sectional Study of Public Health Facilities in Western Kenya by Charles Oduor Opondo, Patrick Ogola Onyango, Collins Otieno Asweto

Connect to this object online.

Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP) by Joanna C. Thorn, Emma L. Turner, Eleanor I. Walsh, Jenny L. Donovan, David E. Neal, Freddie C. Hamdy, Richard M. Martin, Sian M. Noble

Connect to this object online.

MicroRNA 138 Upregulation is Associated with Decreasing Levels of CCND1 Gene Expression and Promoting Cell Death in Human Prostate Cancer Cell Lines by Nasrin Haghighi-Najafabadi, Shima Fayaz, Mahboubeh Berizi, Ghazal Haddad, Pezhman Fard-Esfahani

Connect to this object online.

Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells by Zhou ZW, Li XX, He ZX, Pan ST, Yang Y, Zhang X, Chow K, Yang T, Qiu JX, Zhou Q, Tan J, Wang D, Zhou SF

Connect to this object online.

Prostate cancer screening behaviors and its related cognitive psychological factors among men over 50 years of age using the Health Belief Model by Majid Barati, Saeed Bashirian, Mohammad Ali Amirzarghar, Amirabbas Mousali, Mohammad Hassan Saatiasr

Connect to this object online.

Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis by Emily C. Chiang, Shuren Shen, Seema S. Kengeri, Huiping Xu, Gerald F. Combs, J. Steven Morris, David G. Bostwick, David J. Waters

Connect to this object online.

The Impact of Icariside II on Human Prostate Cancer Cell Proliferation, Mobility, and Autophagy via PI3K-AKT-mTOR Signaling Pathway by Li S, Zhan Y, Xie Y, Wang Y, Liu Y

Connect to this object online.

CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression by Janeen H. Trembley, Betsy T. Kren, Md. J. Abedin, Daniel P. Shaughnessy, Yingming Li, Scott M. Dehm, Khalil Ahmed

Connect to this object online.

Development and therapeutic evaluation of 5D3(CC-MLN8237)3.2 antibody-theranostic conjugates for PSMA-positive prostate cancer therapy by Ioanna Liatsou, Betelhem Assefa, Wathsala Liyanage, Sharmane Surasinghe, Zora Nováková, Cyril Bařinka, Kathleen Gabrielson, Kathleen Gabrielson, Venu Raman, Venu Raman, Venu Raman, Venu Raman, Dmitri Artemov, Dmitri Artemov, Sudath Hapuarachchige, Sudath Hapuarachchige

Connect to this object online.

Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells by Namrata Khurana, Partha K. Chandra, Hogyoung Kim, Asim B. Abdel-Mageed, Debasis Mondal, Suresh C. Sikka

Connect to this object online.

WITHDRAWN: JUN and ATF3 are deficient in prostate cancer patients and their delivery in vivo via lipid nanoparticles has therapeutic efficacy by enhancing immune surveillance by Liang Kan, Yongye Huang, Zhongyuan Liu

Connect to this object online.

Prostate Cancer Screening Behaviors Based on the Health Belief Model in Men Aged 40-70 Years in Fasa City, Fars Province, Iran, in 2019 by Ali Khani Jeihooni, Mehdi Amirkhani, Hamideh Mirshekari, Seyyed Mansour Kashfi

Connect to this object online.